# A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.

> **NCT06188026** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 34 (actual)

## Conditions studied

- Healthy Volunteers (Non-alcoholic Steatohepatitis)

## Interventions

- **DRUG:** NNC0194-0499
- **DRUG:** ethinylestradiol/levonorgestrel

## Key facts

- **NCT ID:** NCT06188026
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-18
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06188026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06188026, "A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06188026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*